FDA Approves Treatment For Rare Neurologic Disease (Medical News Today)
The U.S. Food and Drug Administration announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms. The FDA designated Gamunex as an orphan drug to treat CIDP.

Ranbaxy tanks on FDA ruling (Business Standard India)
India s largest drug maker Ranbaxy Laboratories, which derives roughly a quarter of its annual revenues from the US, faces the strong possibility of taking a hit on earnings as a result of the Food and Drug Administration (FDA) blocking the sale of 30 generic medicines from a portfolio of 130 that it retails in the world s largest drug market.